CAWM
ABBV icon

Capital A Wealth Management’s AbbVie ABBV Stock Holding History

Capital A Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$37.3K Sell
241
-463
-66% -$86K 0.42% 76
2025
Q1 		$147K Buy
704
+15
+2% +$2.92K 0.15% 84
2024
Q4 		$122K Buy
+689
New +$127K 0.2% 97

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Capital A Wealth Management's ABBV Position: Q2 2025 in Review

Capital A Wealth Management reduced its AbbVie (ABBV) stake by 66% in Q2 2025, selling an estimated $86K and leaving 241 shares worth $37.3K. The position accounts for 0.42% of the portfolio, ranked #76.

Capital A Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 3 quarters since. The position peaked at $147K in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Capital A Wealth Management held 241 shares of AbbVie worth $37.3K as of Q2 2025.
  • Capital A Wealth Management sold 463 AbbVie shares in Q2 2025, an estimated $86K.
  • AbbVie made up 0.42% of Capital A Wealth Management's portfolio in Q2 2025, its #76 holding.
  • Capital A Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 3 quarters since.
  • Capital A Wealth Management's AbbVie position peaked at $147K in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Capital A Wealth Management's 13F filing for Q2 2025, filed 26 Sep 2025.